Politics By Lev Facher A court struck down a ban on pharma ‘price gouging.’ One state wants to revive it — and others could follow
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Feds may soon charge generic drug makers for price fixing
First Opinion By Farasat A.S. Bokhari Clinton’s proposed ban on pay-for-delay deals would do little to lower drug prices
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Was the FDA commissioner paid by drug makers last year?
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Endo may sell assets as reliance on price hikes wanes
Pharmalot By Ed Silverman India makes it easier to buy its generic drug makers, but will anyone bite?
Pharmalot By Ed Silverman Former FDA official charged with securities fraud for tipping off hedge fund
The Pharmalot View By Ed Silverman Generic drug labels don’t always list known side effects. It’s time to change that